Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Opat

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Blood Advances|December 3, 2024
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemiaBenjamin M Heyman, Stephen S Opat, Björn E Wahlin, et al.
Blood|March 2, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trialJeff P Sharman, Luca Laurenti, Emmanuelle France Ferrant, et al.
Cancers|June 10, 2022
Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in AustraliaMichael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Cancer Epidemiology|September 4, 2022
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control studyMichael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Frontiers in Nutrition|January 23, 2023
Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control studyMichael K Odutola, Marina T van Leeuwen, Julie K Bassett, et al.
Blood Advances|August 19, 2025
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studiesConstantine S Tam, Mary Ann Anderson, Martin Simkovic, et al.
British Journal of Cancer|July 30, 2014
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaC Y Cheah, K E Herbert, K O'Rourke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIAMazyar Shadman, Talha Munir, Tadeusz Robak, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Blood Advances|December 3, 2024
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemiaBenjamin M Heyman, Stephen S Opat, Björn E Wahlin, et al.
Blood|March 2, 2026
Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trialJeff P Sharman, Luca Laurenti, Emmanuelle France Ferrant, et al.
Cancers|June 10, 2022
Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in AustraliaMichael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Cancer Epidemiology|September 4, 2022
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control studyMichael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Frontiers in Nutrition|January 23, 2023
Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control studyMichael K Odutola, Marina T van Leeuwen, Julie K Bassett, et al.
Blood Advances|August 19, 2025
Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studiesConstantine S Tam, Mary Ann Anderson, Martin Simkovic, et al.
British Journal of Cancer|July 30, 2014
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaC Y Cheah, K E Herbert, K O'Rourke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIAMazyar Shadman, Talha Munir, Tadeusz Robak, et al.
Pageof 4